ERBB2 and breast cancer: Most importantly, we found that cancer cells of HER2+ BC and TNBC, especially TNBC, specifically expressed genes that responded to chemical and oxidative stress compared with luminal BC and HER2+ BC, which were related to the high drug resistance of TNBC (Figure 3B) [41,42,43].